✦ LIBER ✦

Improvement of Congestive Heart Failure by Upgrading of Conventional to Resynchronization Pacemakers

✍ Scribed by IBRAHIM MARAI; OSNAT GUREVITZ; SHEMY CARASSO; EYAL NOF; DAVID BAR-LEV; DAVID LURIA; YARON ARBEL; DOV FREIMARK; MICHA S. FEINBERG; MICHAEL ELDAR; MICHAEL GLIKSON

Book ID: 109201126
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 159 KB
Volume: 29
Category: Article
ISSN: 0147-8389
DOI: 10.1111/j.1540-8159.2006.00455.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of efficacy of low-dose spironolact

Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs

✍ S. SCHULLER; N. VAN ISRAËL; S. VANBELLE; C. CLERCX; K. McENTEE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Use of a comprehensive numerical model t

Use of a comprehensive numerical model to improve biventricular pacemaker temporization in patients affected by heart failure undergoing to CRT-D therapy

✍ A. Di Molfetta; L. Santini; G. B. Forleo; M. Cesario; C. Tota; M. Sgueglia; D. S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 493 KB

Rosiglitazone improves the natriuretic r

Rosiglitazone improves the natriuretic response to atrial natriuretic peptide in rats with experimental congestive heart failure: possible involvement of a post-guanylate cyclase mechanism

✍ Ilia Goltsman; Elena Ovcharenko; Aaron Hoffman; Giora Feuerstein; Zaid Abassi; J 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 247 KB

Thrombolysis and Counterpulsation to Imp

Thrombolysis and Counterpulsation to Improve Survival in Myocardial Infarction Complicated by Hypotension and Suspected Cardiogenic Shock or Heart Failure: Results of the TACTICS Trial

✍ E. Magnus Ohman; John Nanas; Robert J. Stomel; Massoud A. Leesar; Dennis W. T. N 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 425 KB

Letter to the Editor re: the Letter to t

Letter to the Editor re: the Letter to the Editor by Dr. David Samuel Henry Bell, MD regarding “The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis”

✍ Robert S. Zimmerman; Kevin Matthew Pantalone 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 82 KB